1149336 Ontario, Inc.
Patent Owner
Stats
- 22 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jan 07, 2016 most recent publication
Details
- 22 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,072 Total Citation Count
- Apr 14, 1995 Earliest Filing
- 13 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9044424 Methods of regulating glucose metabolism, and reagents related theretoJul 25, 13Jun 02, 15[A61K]
8513190 Method of regulating glucose metabolism, and reagents related theretoNov 16, 11Aug 20, 13[A61K]
8318669 Method of regulating glucose metabolism, and reagents related theretoNov 09, 10Nov 27, 12[A61K]
7829530 Method of regulating glucose metabolism, and reagents related theretoNov 26, 08Nov 09, 10[A61K]
7459428 Method of regulating glucose metabolism, and reagents related theretoJul 17, 06Dec 02, 08[A61K]
7157429 Method of regulating glucose metabolism, and reagents related theretoJul 28, 00Jan 02, 07[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0000,857 Method of Regulating Glucose Metabolism, and Reagents Related TheretoAbandonedMay 13, 15Jan 07, 16[A61K]
2014/0213,518 METHODS OF ENHANCING FUNCTIONING OF THE LARGE INTESTINEAbandonedNov 05, 13Jul 31, 14[C07K]
8603976 Methods of enhancing functioning of the large intestineExpiredAug 30, 12Dec 10, 13[A61K, A61P]
8278273 Methods of enhancing functioning of the large intestineExpiredMay 06, 11Oct 02, 12[A61K, G01N]
2011/0223,108 GLUCAGON-LIKE PEPTIDE-2 AND ITS THERAPEUTIC USEAbandonedDec 22, 10Sep 15, 11[A61K, A61P, C07K]
2004/0132,025 Ampk-related serine/threonine kinase, designated snarkAbandonedJul 02, 03Jul 08, 04[C07H, C12Q, C12N]
2003/0109,449 Antagonists of intestinotrophic GLP-2 peptidesAbandonedNov 18, 02Jun 12, 03[A61K, G01N, C07K]
2002/0045,173 GLP-2 receptor gene promoter and uses thereofAbandonedApr 13, 01Apr 18, 02[C07H, C12Q, C12P, C12N, A01K, C07K]
5846937 Method of using exendin and GLP-1 to affect the central nervous systemExpiredMar 03, 97Dec 08, 98[A61K, C07K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.